Ukuhlolwa Okusha Komtholampilo Ezigulini Ezine-Critical COVID-19 Pneumonia

A BAMBA MahhalaRelease 2 | eTurboNews | eTN
Isithombe sikaLinda Hohnholz
Ibhalwe ngu Linda Hohnholz

I-CalciMedica Inc., inkampani yesiteshi se-CRAC (calcium release-activated activated calcium), namuhla imemezele ukuqaliswa kwe-CARDEA-Plus, isivivinyo somtholampilo seSigaba 2b esiqhutshwa e-United States naseCanada, esingase sibe phambili esiGabeni saso. Uhlelo olu-3 lokuthuthukisa lwe-Auxora™ ezigulini ezinenyumoniya ye-COVID-19 ebalulekile.

Ukuhlolwa kuklanyelwe ukuqoqa idatha eyengeziwe yokuphepha kwesiguli nge-Auxora, ukuhlola ukuphepha nokusebenza kwe-Auxora ngokuhambisana nakho kokubili i-tocilizumab ne-corticosteroids, nokuhlola ukuphepha nokusebenza ngempumelelo kwezinsuku ezintathu uma ziqhathaniswa nesithupha zomthamo. Inkampani isanda kubika idatha ephezulu evela ocwaningweni lwayo lweSigaba 2 se-CARDEA esekela izifundo ezengeziwe kulesi sibalo seziguli. 

I-CARDEA-Plus izobhalisa iziguli ezinenyumoniya ze-COVID-19 ezinesilinganiso se-PaO2/FiO2 (P/F) esingu-≤200 ezidinga i-high-flow nasal cannula (HFNC) noma i-noninvasive ventilation (NIV). Iziguli zizothola umthamo wokuqala we-Auxora ongu-2.0 mg/kg olandelwa ngu-1.6 mg/kg emahoreni angama-24, kanye no-1.6 mg/kg emahoreni angama-48. Lezo ziguli ezinesilinganiso se-P/F esingu-≤100 noma ekungeniseni umoya ngomshini emahoreni angu-48 zizofaneleka ukuhlelwa ngokungahleliwe ukuze zithole imithamo emithathu ye-Auxora noma imithamo emithathu ye-placebo. Zonke iziguli zizothola ukunakekelwa okujwayelekile okungase kuhlanganise ukusetshenziswa kwe-corticosteroids kanye/noma i-tocilizumab.

"Naphezu kokwenyuka kwamazinga okugomela i-COVID-19, isibalo esiphezulu sokulaliswa kanye nokufa kwabantu sisadala inkinga enkulu," kusho uSudarshan Hebbar, MD, Isikhulu Esiphezulu Sezokwelapha saseCalciMedica. “Yize i-tocilizumab isisetshenziswa kabanzi ezigulini ezilaliswe esibhedlela ezine-COVID-19, kusaqhubeka kunesidingo sokuthuthukisa imiphumela yesiguli. Sikholelwa ukuthi i-Auxora inendlela ehlukile yokwenza kanye nezakhiwo ze-pharmacokinetic ezingahlinzeka ngenzuzo yomtholampilo ezigulini ezinenyumoniya ye-COVID-19 ebucayi. "

"Ukuqaliswa kwalolu cwaningo, oluphinde luvumele ukuphathwa kwe-Auxora ene-tocilizumab kanye ne-corticosteroids ezigulini ezinenyumoniya ebucayi ye-COVID-19, kuyingqophamlando eNkampanini yethu," kusho uRachel Leheny, Ph.D., Isikhulu Esiphezulu seCalciMedica. . “Okubalulekile, imiphumela yalolu cwaningo, ezolandelwa yizingxoxo ne-FDA, izokwazisa ukuklanywa kocwaningo lomtholampilo olungase lweSigaba sesi-3 ngasekupheleni kwalo nyaka. Sithole isasasa nokusekelwa okuvela kumasayithi abaphenyi kulolu cwaningo futhi silindele ukubhaliswa okusheshayo.”

Mayelana umbhali

Isithombe sikaLinda Hohnholz

Linda Hohnholz

Umhleli omkhulu we eTurboNews ezinze eTN HQ.

Bhalisa
Yazisa ngakho
isivakashi
0 Amazwana
Okungaphakathi Okuphakelayo
Buka wonke amazwana
0
Ungathanda imibono yakho, ngicela uphawule.x
Yabelana ku...